USP18 exacerbates myocardial I/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L

Qing-Qing Wu; Yang Xiao; Ying-Ying Hu; Xiang-Yu Yang; Xin-Yi Yan; Ke-Qiong Deng; Zhi-Li Jin; Wei Zhang; Jian-Lei Cao; Li-Hua Ni; Yong-Zhen Fan; Zhi-Bing Lu; Xiao-Rong Hu

doi:10.1016/j.mmr.2026.100004

Your Location：

Home >

Browse articles >

USP18 exacerbates myocardial I/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L

RESEARCH | Updated：2026-08-20

- USP18 exacerbates myocardial I/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L
- USP18 exacerbates myocardial I/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L
- 军事医学研究（英文） 2026年13卷第7期页码：1102-1122
- Affiliations：
  
  Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan 430062, China
  Institute of Myocardial Injury and Repair, Wuhan University, Wuhan 430062, China
  Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China
- Author bio：
  
  *Zhi-Bing Lu, luzhibing@whu.edu.cn;
  Xiao-Rong Hu, huxrzn@whu.edu.cn
- Funds：
  
  the National Natural Science Foundation of China(82470399;82170382;82400401;82370290);the Wuhan University Zhongnan Hospital Translational Medicine and Interdisciplinary Research Joint Fund(ZNJC202308)
- DOI：10.1016/j.mmr.2026.100004
  中图分类号：
- 收稿：2025-06-17，
  
  录用：2026-03-05，
  
  纸质出版：2026-07
- Accepted：
Scan QR Code
Qing-Qing Wu, Yang Xiao, Ying-Ying Hu, 等. USP18 exacerbates myocardial I/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L[J]. 军事医学研究（英文）, 2026,13(7):1102-1122.

Wu QQ, Xiao Y, Hu YY, Yang XY, Yan XY, Deng KQ, et al. USP18 exacerbates myocardial I/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L. Mil Med Res. 2026;13(1):100004.
Qing-Qing Wu, Yang Xiao, Ying-Ying Hu, 等. USP18 exacerbates myocardial I/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L[J]. 军事医学研究（英文）, 2026,13(7):1102-1122. DOI： 10.1016/j.mmr.2026.100004.

Wu QQ, Xiao Y, Hu YY, Yang XY, Yan XY, Deng KQ, et al. USP18 exacerbates myocardial I/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L. Mil Med Res. 2026;13(1):100004. DOI： 10.1016/j.mmr.2026.100004.

摘要

Abstract

Background:

Mitochondrial quality control is essential for limiting myocardial injury induced by ischemia/reperfusion(I/R)

a major contributor to adverse outcomes after reperfusion therapy. This study aimed to determine whether the deubiquitinase ubiquitin-specific protease 18 (USP18) regulates mitophagy during cardiac I/R injury and thereby represents a potential therapeutic target to attenuate myocardial I/R injury.

Methods:

Cardiac-specific

USP18

knockout mice were subjected to cardiac I/R injury. To elucidate the role of USP18 in mitophagy regulation and cardiac I/R injury

we performed RNA sequencing

proteomic mass spectrometry

transmission electron microscopy

and mitophagy assays. In parallel

adeno-associated virus serotype 9 (AAV9)-mediated overexpression of USP18

knockdown of

Parkin

and phosphatase and tensin homolog-long (

PTEN-L

)

and administration of an anti-PTEN-L neutralizing antibody were used to elucidate the underlying mechanisms. Additionally

serum samples from patients with ST-segment elevation myocardial infarction (STEMI) were collected to assess clinical relevance.

Results:

USP18 expression was upregulated in mouse hearts following I/R injury and in ischemic human heart tissue. Cardiac-specific

USP18

deficiency mitigated I/R-induced acute myocardial injury

mitochondrial dysfunction

and adverse cardiac remodeling

whereas USP18 overexpression exacerbated these pathological changes. Mechanistically

USP18 interacted with PTEN-L

which in turn bound to and inhibited the phosphorylation and translocation of Parkin to mitochondria

thereby suppressing mitophagy.

Parkin

knockdown abolished the cardioprotective effects conferred by

USP18

deficiency

whereas

PTEN-L

knockdown reversed the detrimental effect of USP18 overexpression. Moreover

PTEN-L also exerted pathogenic effects via a paracrine mechanism

as neutralizing PTEN-L with an antibody attenuated cardiac I/R injury. Serum PTEN-L levels were elevated in STEMI patients

particularly postintervention.

Conclusions:

USP18 impairs mitophagy and exacerbates cardiac I/R injury through a PTEN-L-Parkin axis

involving both intracellular and paracrine mechanisms. Targeting the USP18-PTEN-L pathway may represent a novel therapeutic strategy to alleviate myocardial I/R injury.

关键词

Keywords

references

Dauerman HL , Ibanez B . The edge of time in acute myocardial infarction . J Am Coll Cardiol . 2021 ; 77 ( 15 ): 1871 - 4 .

Bahit MC , Kochar A , Granger CB . Post-myocardial infarction heart failure . JACC Heart Fail . 2018 ; 6 ( 3 ): 179 - 86 .

Ibanez B , James S , Agewall S , Antunes MJ , Bucciarelli-Ducci C , Bueno H , et al . 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation . Rev Esp Cardiol (Engl Ed) . 2017 ; 70 ( 12 ): 1082 .

Algoet M , Janssens S , Himmelreich U , Gsell W , Pusovnik M , Van den Eynde J , et al . Myocardial ischemia-reperfusion injury and the influence of inflammation . Trends Cardiovasc Med . 2023 ; 33 ( 6 ): 357 - 66 .

Zhou M , Yu Y , Luo X , Wang J , Lan X , Liu P , et al . Myocardial ischemia-reperfusion injury: therapeutics from a mitochondria-centric perspective . Cardiology . 2021 ; 146 ( 6 ): 781 - 92 .

Yang M , Linn BS , Zhang Y , Ren J . Mitophagy and mitochondrial integrity in cardiac ischemia-reperfusion injury . Biochim Biophys Acta Mol Basis Dis . 2019 ; 1865 ( 9 ): 2293 - 302 .

Cai C , Guo Z , Chang X , Li Z , Wu F , He J , et al . Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway . Redox Biol . 2022 ; 52 : 102288 .

Narendra DP , Youle RJ . The role of PINK1-Parkin in mitochondrial quality control . Nat Cell Biol . 2024 ; 26 ( 10 ): 1639 - 51 .

Ai L , de Freitas Germano J , Huang C , Aniag M , Sawaged S , Sin J , et al . Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodelling after myocardial infarction: role of PR-364 . Eur Heart J . 2025 ; 46 ( 4 ): 380 - 93 .

Kubli DA , Zhang X , Lee Y , Hanna RA , Quinsay MN , Nguyen CK , et al . Parkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarction . J Biol Chem . 2013 ; 288 ( 2 ): 915 - 26 .

Wang L , Cho YL , Tang Y , Wang J , Park JE , Wu Y , et al . PTEN-L is a novel protein phosphatase for ubiquitin dephosphorylation to inhibit PINK1-Parkin-mediated mitophagy . Cell Res . 2018 ; 28 ( 8 ): 787 - 802 .

Zhang N , Zhang Y , Qian H , Wu S , Cao L , Sun Y . Selective targeting of ubiquitination and degradation of PARP1 by E3 ubiquitin ligase WWP2 regulates isoproterenol-induced cardiac remodeling . Cell Death Differ . 2020 ; 27 ( 9 ): 2605 - 19 .

Popovic D , Vucic D , Dikic I . Ubiquitination in disease pathogenesis and treatment . Nat Med . 2014 ; 20 ( 11 ): 1242 - 53 .

Niu K , Fang H , Chen Z , Zhu Y , Tan Q , Wei D , et al . USP33 deubiquitinates PRKN/Parkin and antagonizes its role in mitophagy . Autophagy . 2020 ; 16 ( 4 ): 724 - 34 .

Xie SY , Liu SQ , Zhang T , Shi WK , Xing Y , Fang WX , et al . USP28 serves as a key suppressor of mitochondrial morphofunctional defects and cardiac dysfunction in the diabetic heart . Circulation . 2024 ; 149 ( 9 ): 684 - 706 .

Zhang M , Zhang MX , Zhang Q , Zhu GF , Yuan L , Zhang DE , et al . USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING/MITA . Cell Res . 2016 ; 26 ( 12 ): 1302 - 19 .

Arimoto KI , Miyauchi S , Troutman TD , Zhang Y , Liu M , Stoner SA , et al . Expansion of interferon inducible gene pool via USP18 inhibition promotes cancer cell pyroptosis . Nat Commun . 2023 ; 14 ( 1 ): 251 .

Hou J , Han L , Zhao Z , Liu H , Zhang L , Ma C , et al . USP18 positively regulates innate antiviral immunity by promoting K63-linked polyubiquitination of MAVS . Nat Commun . 2021 ; 12 ( 1 ): 2970 .

Ying X , Zhao Y , Yao T , Yuan A , Xu L , Gao L , et al . Novel protective role for ubiquitin-specific protease 18 in pathological cardiac remodeling . hypertension . 2016 ; 68 ( 5 ): 1160 - 70 .

Wu QQ , Liu C , Cai Z , Xie Q , Hu T , Duan M , et al . High-mobility group AT-hook 1 promotes cardiac dysfunction in diabetic cardiomyopathy via autophagy inhibition . Cell Death Dis . 2020 ; 11 ( 3 ): 160 .

Liu C , Hu T , Cai Z , Xie Q , Yuan Y , Li N , et al . Nucleotide-binding oligomerization domain-like receptor 3 deficiency attenuated isoproterenol-induced cardiac fibrosis via reactive oxygen species/high mobility group box 1 protein axis . Front Cell Dev Biol . 2020 ; 8 : 713 .

Nunes JPS , Andrieux P , Brochet P , Almeida RR , Kitano E , Honda AK , et al . Co-exposure of cardiomyocytes to IFN-γ and TNF-α induces mitochondrial dysfunction and nitro-oxidative stress: implications for the pathogenesis of chronic chagas disease cardiomyopathy . Front Immunol . 2021 ; 12 : 755862 .

Liu W , Deng J , Xu J , Wang H , Yuan M , Liu N , et al . High-mobility group box 1 (HMGB1) downregulates cardiac transient outward potassium current (Ito) through downregulation of Kv4.2 and Kv4.3 channel transcripts and proteins . J Mol Cell Cardiol . 2010 ; 49 ( 3 ): 438 - 48 .

Wu QQ , Yao Q , Hu TT , Wan Y , Xie QW , Zhao JH , et al . Tax1 banding protein 1 exacerbates heart failure in mice by activating ITCH-P73-BNIP3-mediated cardiomyocyte apoptosis . Acta Pharmacol Sin . 2022 ; 43 ( 10 ): 2562 - 72 .

Gomez D , Baylis RA , Durgin BG , Newman AAC , Alencar GF , Mahan S , et al . Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice . Nat Med . 2018 ; 24 ( 9 ): 1418 - 29 .

Kang JA , Jeon YJ . Emerging roles of USP18: from biology to pathophysiology . Int J Mol Sci . 2020 ; 21 ( 18 ): 6825 .

Ashrafi G , Schwarz TL . The pathways of mitophagy for quality control and clearance of mitochondria . Cell Death Differ . 2013 ; 20 ( 1 ): 31 - 42 .

Mizumura K , Cloonan SM , Nakahira K , Bhashyam AR , Cervo M , Kitada T , et al . Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD . J Clin Invest . 2014 ; 124 ( 9 ): 3987 - 4003 .

Mustachio LM , Kawakami M , Lu Y , Rodriguez-Canales J , Mino B , Behrens C , et al . The ISG15-specific protease USP18 regulates stability of PTEN . Oncotarget . 2017 ; 8 ( 1 ): 3 - 14 .

Shiba-Fukushima K , Arano T , Matsumoto G , Inoshita T , Yoshida S , Ishihama Y , et al . Phosphorylation of mitochondrial polyubiquitin by PINK1 promotes Parkin mitochondrial tethering . PLoS Genet . 2014 ; 10 ( 12 ): e1004861 .

Ketscher L , Hannss R , Morales DJ , Basters A , Guerra S , Goldmann T , et al . Selective inactivation of USP18 isopeptidase activity in vivo enhances ISG15 conjugation and viral resistance . Proc Natl Acad Sci U S A . 2015 ; 112 ( 5 ): 1577 - 82 .

Hopkins BD , Fine B , Steinbach N , Dendy M , Rapp Z , Shaw J , et al . A secreted PTEN phosphatase that enters cells to alter signaling and survival . Science . 2013 ; 341 ( 6144 ): 399 - 402 .

Dziamałek-Macioszczyk P , Harazny JM , Kwella N , Wojtacha P , Jung S , Dienemann T , et al . Relationship between ubiquitin-specific peptidase 18 and hypertension in Polish adult male subjects: a cross-sectional pilot study . Med Sci Monit . 2020 ; 26 : e921919 .

Wang S , Long H , Hou L , Feng B , Ma Z , Wu Y , et al . The mitophagy pathway and its implications in human diseases . Signal Transduct Target Ther . 2023 ; 8 ( 1 ): 304 .

Forte M , D'Ambrosio L , Schiattarella GG , Salerno N , Perrone MA , Loffredo FS , et al . Mitophagy modulation for the treatment of cardiovascular diseases . Eur J Clin Invest . 2024 ; 54 ( 8 ): e14199 .

Rabinovich-Nikitin I , Rasouli M , Reitz CJ , Posen I , Margulets V , Dhingra R , et al . Mitochondrial autophagy and cell survival is regulated by the circadian Clock gene in cardiac myocytes during ischemic stress . Autophagy . 2021 ; 17 ( 11 ): 3794 - 812 .

Zhang H , Yang N , He H , Chai J , Cheng X , Zhao H , et al . The zinc transporter ZIP7 (Slc39a7) controls myocardial reperfusion injury by regulating mitophagy . Basic Res Cardiol . 2021 ; 116 ( 1 ): 54 .

Ma ZR , Xiong QW , Cai SZ , Ding LT , Yin CH , Xia HL , et al . USP18 enhances the resistance of BRAF-mutated melanoma cells to vemurafenib by stabilizing cGAS expression to induce cell autophagy . Int Immunopharmacol . 2023 ; 122 : 110617 .

Wang L , Lu G , Shen HM . The long and the short of PTEN in the regulation of mitophagy . Front Cell Dev Biol . 2020 ; 8 : 299 .

Degli Esposti M . Did mitophagy follow the origin of mitochondria? . Autophagy . 2024 ; 20 ( 5 ): 985 - 93 .

Onishi M , Yamano K , Sato M , Matsuda N , Okamoto K . Molecular mechanisms and physiological functions of mitophagy . EMBO J . 2021 ; 40 ( 3 ): e104705 .

Cai J , Li R , Xu X , Zhang L , Lian R , Fang L , et al . CK1α suppresses lung tumour growth by stabilizing PTEN and inducing autophagy . Nat Cell Biol . 2018 ; 20 ( 4 ): 465 - 78 .

Liang H , He S , Yang J , Jia X , Wang P , Chen X , et al . PTENα, a PTEN isoform translated through alternative initiation, regulates mitochondrial function and energy metabolism . Cell Metab . 2014 ; 19 ( 5 ): 836 - 48 .

Song X , He J , Shi B , Han Y . Hypoxic microenvironment-induced reduction in PTEN-L secretion promotes non-small cell lung cancer metastasis through PI3K/Akt pathway . Evid Based Complement Alternat Med . 2022 ; 2022 : 6683104 .

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Antibacterial efficacy of a chitosan-based hydrogel loaded with epsilon poly-L-lysine and poly(I:C) extracellular vesicles for the control of polymicrobial extremity wound infections in a porcine polytrauma model

Pathophysiology-guided biomarkers and therapeutics for precision trauma medicine in polytrauma with musculoskeletal injuries

National and subnational burden and causes of anemia in China from 1990 to 2023: findings from the Global Burden of Disease Study 2023

Burden of antimicrobial resistance in the WHO Southeast Asia and Western Pacific Regions, 1990–2021: a cross-country systematic analysis with forecasts to 2050

Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis